SCHEMBL30879031

SCHEMBL30879031

CC(C)[Si](C#Cc1cc(=O)n(-c2ccccc2)c2nc(Nc3ccc(C4CCN(C)CC4)cc3)ncc12)(C(C)C)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 5/20 0.48
CDK4 P11802 2/20 0.47
CCND1 P24385 2/20 0.47
CCND2 P30279 2/20 0.47
CCND3 P30281 2/20 0.47
MAP4K1 Q92918 3/20 0.46
KCNH2 Q12809 1/20 0.46
BRD4 O60885 3/20 0.45
JAK2 O60674 2/20 0.45
CSF1R P07333 4/20 0.44
PLK1 P53350 2/20 0.44
STAT6 P42226 1/20 0.42
NTRK1 P04629 1/20 0.42
INSR P06213 1/20 0.42
PDGFRB P09619 1/20 0.42
KIT P10721 1/20 0.42
SRC P12931 1/20 0.42
FLT3 P36888 1/20 0.42
NUAK1 O60285 1/20 0.42
MARK3 P27448 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879080 0.91 BTK (0.47) WEE1CDK4CCND1CCND2CCND3
SCHEMBL30879161 0.87 CCND3 (0.48) CDK4CCND1CCND2CCND3BRD4
SCHEMBL30878381 0.87 WEE1 (0.53) WEE1CDK4CCND1CCND2CCND3
SCHEMBL30879109 0.86 CDK4 (0.53) WEE1CDK4CCND1CCND2CCND3
SCHEMBL30878852 0.86 EGFR (0.56) CDK4CCND1CCND2CCND3MAP4K1
SCHEMBL30878988 0.83 CCND3 (0.51) WEE1CDK4CCND1CCND2CCND3
SCHEMBL30878983 0.83 FLT3 (0.55) CDK4CCND1CCND2CCND3BRD4
SCHEMBL30879056 0.83 CDK4 (0.47) WEE1CDK4CCND1CCND2CCND3
SCHEMBL30878950 0.83 MAP4K1 (0.43) WEE1CDK4CCND1CCND2CCND3
SCHEMBL30879189 0.83 CDK4 (0.52) WEE1CDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed